Urmicos Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 19-12-2024
- Paid Up Capital ₹ 0.40 M
as on 19-12-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 M
as on 19-12-2024
- Revenue %
(FY 2022)
- Net Worth 6.97%
(FY 2022)
- Total Assets 104.63%
(FY 2022)
About Urmicos Biotech
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹3.00 M.
Anand Dixit and Anjali Dixit serve as directors at the Company.
- CIN/LLPIN
U51909MP2021PTC054696
- Company No.
054696
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Feb 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Bhopal, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Urmicos Biotech Private Limited offer?
Urmicos Biotech Private Limited offers a wide range of products and services, including Common Disease Medicines, Hair Growth Medicine.
Who are the key members and board of directors at Urmicos Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Dixit  | Director | 01-Feb-2021 | Current |
| Anjali Dixit | Director | 01-Feb-2021 | Current |
Financial Performance of Urmicos Biotech.
Urmicos Biotech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 6.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Urmicos Biotech?
Unlock access to Urmicos Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 06 Mar 2024 | ₹2.00 M | Open |
Bank Of India Creation Date: 14 Aug 2023 | ₹1.00 M | Open |
How Many Employees Work at Urmicos Biotech?
Urmicos Biotech has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Urmicos Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Urmicos Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
